US Stock MarketDetailed Quotes
RKDA Arcadia Biosciences
- 4.1600
- +0.4000+10.64%
Close Nov 6 16:00 ET
- 4.1600
- 0.00000.00%
Post 20:01 ET
5.67MMarket Cap-904P/E (TTM)
4.3843High3.7940Low23.08KVolume3.7940Open3.7600Pre Close94.03KTurnover1.71%Turnover RatioLossP/E (Static)1.36MShares5.340052wk High0.48P/B5.63MFloat Cap1.851252wk Low--Dividend TTM1.35MShs Float7039.9965Historical High--Div YieldTTM15.70%Amplitude1.8512Historical Low4.0740Avg Price1Lot Size
Arcadia Biosciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.69%1.31M | 1.87%1.26M | -28.15%5.33M | 57.26%1.17M | 1.72%1.6M | -66.38%1.3M | -61.74%1.23M | 9.41%7.42M | -65.73%744K | -33.92%1.57M |
| Operating revenue | 0.69%1.31M | 1.87%1.26M | -28.15%5.33M | 57.26%1.17M | 1.72%1.6M | -66.38%1.3M | -61.74%1.23M | 9.41%7.42M | -65.73%744K | -33.92%1.57M |
| Cost of revenue | -2.62%633K | 19.19%820K | -45.91%3.3M | -25.56%670K | -2.30%1.1M | -81.14%650K | -80.10%688K | -29.94%6.1M | -76.03%900K | -55.08%1.13M |
| Gross profit | 4.02%673K | -20.04%435K | 54.14%2.03M | 420.51%500K | 11.99%495K | 57.42%647K | 328.57%544K | 168.31%1.32M | 90.15%-156K | 427.41%442K |
| Operating expense | 28.18%2.69M | -21.87%3.46M | -3.93%15.9M | -9.06%3.76M | -15.45%3.75M | -58.07%2.1M | -6.62%4.43M | -38.33%16.55M | -38.97%4.13M | -39.69%4.43M |
| Selling and administrative expenses | 29.36%2.68M | -21.67%3.19M | -3.51%14.51M | -5.68%3.42M | -17.59%3.44M | -55.42%2.07M | -6.39%4.07M | -34.45%15.04M | -41.51%3.63M | -33.81%4.18M |
| Research and development costs | -62.96%10K | -24.23%272K | -8.08%1.39M | -33.60%332K | 19.61%305K | -92.48%27K | -9.11%359K | -61.20%1.51M | -10.87%500K | -75.43%255K |
| Operating profit | -38.93%-2.02M | 22.13%-3.03M | 8.95%-13.87M | 24.04%-3.26M | 18.49%-3.25M | 68.39%-1.45M | 22.00%-3.89M | 47.04%-15.23M | 48.68%-4.29M | 46.68%-3.99M |
| Net non-operating interest income expense | -27.54%150K | -77.27%45K | 140.48%695K | -5.42%157K | 40.00%133K | 590.00%207K | 19,900.00%198K | 1,545.00%289K | 5,433.33%166K | 733.33%95K |
| Non-operating interest income | -27.54%150K | -77.27%45K | 140.48%695K | -5.42%157K | 40.00%133K | 590.00%207K | --198K | --289K | --166K | --95K |
| Other net income (expense) | -15.51%3.72M | 110.12%558K | -99.68%13K | -49.37%482K | -60.47%636K | 469.60%4.4M | -1,578.55%-5.52M | -67.37%4.13M | 178.68%952K | -65.51%1.61M |
| Gain on sale of security | -109.74%-430K | 111.55%593K | -85.42%468K | -56.43%579K | -67.66%608K | --4.42M | ---5.14M | -64.13%3.21M | -69.41%1.33M | -60.64%1.88M |
| Earnings from equity interest | ---- | --0 | ---- | ---- | ---- | ---- | ---430K | ---- | ---- | ---- |
| Special income (charges) | --4M | -300.00%-38K | -105.98%-73K | 70.78%-109K | --11K | --0 | -94.71%19K | 121.62%1.22M | 93.16%-373K | --0 |
| -Less：Restructuring and merger&acquisition | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 66.67%-70K | --0 | --0 |
| -Less:Impairment of capital assets | --0 | --36K | -62.46%113K | ---- | ---- | --0 | --0 | -95.36%301K | ---- | ---- |
| -Gain on sale of business | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --1.14M | --0 | --0 |
| -Gain on sale of property,plant,equipment | --4M | -110.53%-2K | -87.26%40K | 105.56%4K | --11K | --0 | -94.21%19K | 163.18%314K | 85.00%-72K | --0 |
| Other non- operating income (expenses) | 1,253.85%150K | -90.63%3K | -25.25%-382K | 400.00%12K | 106.27%17K | 70.45%-13K | 128.57%32K | -103.26%-305K | 96.00%-4K | -3,771.43%-271K |
| Income before tax | -41.38%1.85M | 73.67%-2.42M | -21.67%-13.16M | 17.40%-2.62M | -8.61%-2.48M | 183.12%3.16M | -99.63%-9.2M | 32.97%-10.81M | 66.86%-3.17M | 19.33%-2.29M |
| Income tax | 0 | -42.86%8K | -46.15%7K | 0 | 1K | 600.00%14K | 1,200.00%13K | 0.00%1K | ||
| Net income | 29.71%1.06M | 74.18%-2.42M | 10.42%-13.99M | 34.08%-2.85M | 10.78%-2.57M | 121.54%818K | -103.56%-9.38M | 3.24%-15.61M | 54.71%-4.33M | -1.45%-2.88M |
| Net income continuous Operations | -41.36%1.85M | 73.67%-2.42M | -21.58%-13.17M | 17.52%-2.62M | -8.57%-2.48M | 183.09%3.16M | -99.63%-9.2M | 32.89%-10.83M | 66.73%-3.18M | 19.32%-2.29M |
| Net income discontinuous operations | 66.24%-789K | --0 | 82.84%-821K | 79.97%-230K | 85.91%-83K | ---2.34M | ---181K | ---4.78M | ---1.15M | ---589K |
| Minority interest income | 0 | 97.88%-5K | 0 | 0 | 75.00%-5K | 83.99%-236K | 69.45%-84K | 98.49%-10K | ||
| Net income attributable to the parent company | 28.92%1.06M | 74.18%-2.42M | 9.07%-13.98M | 32.78%-2.85M | 10.46%-2.57M | 121.79%823K | -109.09%-9.38M | -4.88%-15.38M | 54.28%-4.24M | -31.82%-2.87M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 28.92%1.06M | 74.18%-2.42M | 9.07%-13.98M | 32.78%-2.85M | 10.46%-2.57M | 121.79%823K | -109.09%-9.38M | -4.88%-15.38M | 54.28%-4.24M | -31.82%-2.87M |
| Basic earnings per share | 27.87%0.78 | 83.61%-1.78 | 55.95%-11.3 | 68.31%-1.99 | 59.53%-1.89 | 108.96%0.61 | -34.24%-10.86 | 6.93%-25.65 | 63.40%-6.28 | -16.75%-4.67 |
| Diluted earnings per share | 27.87%0.78 | 83.61%-1.78 | 55.95%-11.3 | 68.31%-1.99 | 59.53%-1.89 | 108.96%0.61 | -34.24%-10.86 | 6.93%-25.65 | 63.40%-6.28 | -16.75%-4.67 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data